Table 2.
Demographic and clinical characteristics of 152 patients
| Variables | Patients (n = 152) |
|---|---|
| Age, mean (SD) [range], years | 32 (4) [22–48] |
| BMI (kg/m2) | |
| ≥ 30 | 8 (5.3%) |
| 25–30 | 64 (42.1%) |
| 18.5–24.99 | 71 (46.7%) |
| < 18.5 | 9 (5.9%) |
| Time interval between birth and onset of GLM (years) | |
| Pregnancy | 15 (9.9%) |
| Breastfeeding | 4 (2.6%) |
| Time until last birth (years) (< 2, no breastfeeding) | 26 (17.1%) |
| Time until last birth (years) (2–5) | 94 (61.8%) |
| Time until last birth (years) (> 5) | 8 (5.3%) |
| No birth | 5 (3.3%) |
| Comorbid disease | |
| Diabetes mellitus | 1 (0.7%) |
| Thyroid disease | 1 (0.7%) |
| Psychoses | 3 (2.0%) |
| Hypertension | 2 (1.3%) |
| Hyperprolactinemia | 21 (13.8%) |
| Side | |
| Left | 81 (53.2%) |
| Right | 59 (38.9%) |
| Bilateral | 12 (7.9%) |
| Sign and symptoms | |
| Palpable mass with pain | 150 (98.7%) |
| Skin lesion | 114 (75%) |
| Abscess | 64 (38.8%) |
| Fistula | 8 (5.3%) |
| Erythema nodosum | 8 (5.3%) |
| Mass size at onset [43] | |
| < 1 cm | 6 (4.2%) |
| 1–2 cm | 40 (26.3%) |
| 3–5 cm | 69 (45.6%) |
| > 5 cm | 36 (23.9%) |
| Laboratory tests before treatment | |
| C. kroppenstedtii | |
| Positive | 36 (23.68%) |
| White blood cell (WBC) mean [range], *109/L | 9.77 ± 3.33 (3.59–17.55) |
| C-reactive protein (CRP) mean [range], mg/L | 11.91 ± 18.91 (1.0–139) |
| Prolactin (PRL) mean [range], ng/mL | 22.70 ± 19.72 (3.5–129.24) |
| Types of GM | |
| Mass type | 74 (48.7%) |
| Abscess type | 66 (43.4%) |
| Refractory type | 12 (7.9%) |
| Behavior before the onset | |
| Breast trauma | 13 (8.6%) |
| Excitant food | 22 (14.47%) |
| Staying up all night | 12 (7.89%) |